Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-02-21 @ 11:37 PM
Study NCT ID:
NCT02166151
Status:
UNKNOWN
Last Update Posted:
2014-06-18
First Post:
2014-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria
Sponsor:
Rabin Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
0550-31 -RMC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None